EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Mapeo epidemiológico de las glomerulopatías primarias en Lima

Raúl Junior Gonzales Navarro, Abdias Nicanor Hurtado Arestegui, Carmen Asato Higa, Julia Sumire Úmeres

Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante · 2025

DOI: 10.56867/111 ↗
AbstractBibliografische Angaben

Abstract

Introduction: Primary glomerulopathies (PG) constitute a heterogeneous group of kidney diseases that primarily affect the glomeruli without an identifiable etiological cause. They present clinically with a wide spectrum of manifestations, ranging from proteinuria, hematuria, and nephrotic syndrome to acute or chronic kidney failure. The epidemiology of GP varies geographically; in Peru, focal segmental glomerulosclerosis (FSGS) has increased significantly, positioning itself as the most prevalent form. Methods: A retrospective study was conducted using kidney biopsies from a referral center in Lima between 2006 and 2015. Patients over 18 years of age with a biopsy-confirmed diagnosis of GP were included. Samples were processed for light microscopy and immunofluorescence, classifying glomerular lesions according to their morphological pattern and type of immune deposits. Results: Of the 1259 GP biopsies, 960 met the inclusion criteria. FSGS was the most common form (67%), followed by membranous glomerulopathy (MG) (21%) and glomerulopathy with a membranoproliferative pattern (MPP) (7%). The annual rate of MG was 13.2 patients per million population. Conclusion: FSGS has doubled its prevalence in the last decade, displacing MPP, suggesting an epidemiological shift in the Peruvian population.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →